133 related articles for article (PubMed ID: 35119394)
1. Amyloid Arthropathy and Pseudomyopathy Associated With Multiple Myeloma Detected by 18F-Florapronol Amyloid PET/CT.
Seo M; Lee YJ; Kim M; Kang BS; Park SH
Clin Nucl Med; 2022 Apr; 47(4):e375-e376. PubMed ID: 35119394
[TBL] [Abstract][Full Text] [Related]
2. Radiologic Findings in Polyarticular Amyloid Arthropathy and Myopathy in Multiple Myeloma: A Case Report.
Khoo HW; Ding CSL; Tandon AA
Am J Case Rep; 2018 Nov; 19():1398-1404. PubMed ID: 30470733
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma.
Son YM; Choi JY; Bak CH; Cheon M; Kim YE; Lee KH; Kim BT
Korean J Radiol; 2011; 12(5):634-7. PubMed ID: 21927567
[TBL] [Abstract][Full Text] [Related]
4. Secondary Gastrointestinal Amyloidosis With Increased 18 F-FDG Uptake as the Only Presentation in a Patient With Multiple Myeloma.
Ding J; Huo L; Cui R; Luo Y
Clin Nucl Med; 2022 Aug; 47(8):721-722. PubMed ID: 35195581
[TBL] [Abstract][Full Text] [Related]
5. Visualization of amyloid arthropathy in light-chain systemic amyloidosis on F-18 FDG PET/CT scan.
Mekinian A; Ghrenassia E; Pop G; Roberts S; Prendki V; Stirnemann J; Weinmann P; Fain O
Clin Nucl Med; 2011 Jan; 36(1):52-3. PubMed ID: 21157212
[TBL] [Abstract][Full Text] [Related]
6. Myocardial Uptake of 68Ga-Pentixafor in a Patient With Systemic Amyloidosis.
Pan Q; Luo Y; Cao X; Li J
Clin Nucl Med; 2022 Dec; 47(12):1118-1120. PubMed ID: 36342801
[TBL] [Abstract][Full Text] [Related]
7. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-MDP SPECT/CT demonstrating extraosseous periarticular amyloid deposits in primary systemic amyloidosis associated with multiple myeloma.
Agarwal KK; Karunanithi S; Roy SG; Bal C; Kumar R
Clin Nucl Med; 2015 Feb; 40(2):189-90. PubMed ID: 25275414
[TBL] [Abstract][Full Text] [Related]
9. Multiple Myeloma Presenting as Disseminated Osteoblastic Lesions With Intense 18F-FDG Uptake on PET/CT.
Wang Y; Fan Q; Su M
Clin Nucl Med; 2021 Oct; 46(10):e492-e495. PubMed ID: 33630796
[TBL] [Abstract][Full Text] [Related]
10. Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis.
Glaudemans AW; Slart RH; Noordzij W; Dierckx RA; Hazenberg BP
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1095-101. PubMed ID: 23474745
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
[TBL] [Abstract][Full Text] [Related]
12. Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma.
Xu F; Liu F; Pastakia B
Clin Nucl Med; 2014 Sep; 39(9):e407-9. PubMed ID: 24217536
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.
Mekinian A; Jaccard A; Soussan M; Launay D; Berthier S; Federici L; Lefèvre G; Valeyre D; Dhote R; Fain O;
Amyloid; 2012 Jun; 19(2):94-8. PubMed ID: 22587492
[TBL] [Abstract][Full Text] [Related]
14. Clinical Utility of 18F-Florbetaben PET for Detecting Amyloidosis Associated With Multiple Myeloma: A Prospective Case-Control Study.
Seo M; Cha HJ; Kim M; Park SH; Lim JH; Choi Y; Lee YJ; Park SH; Jo JC
Clin Nucl Med; 2019 Sep; 44(9):e503-e509. PubMed ID: 31283608
[TBL] [Abstract][Full Text] [Related]
15. Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience.
Elboga U; Sahin E; Cayirli YB; Okuyan M; Aktas G; Haydaroglu Sahin H; Dogan I; Kus T; Akkurd DM; Cimen U; Mumcu V; Kilbas B; Celen YZ
Tomography; 2022 Feb; 8(1):293-302. PubMed ID: 35202189
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma.
Mosci C; Pericole FV; Oliveira GB; Delamain MT; Takahashi MES; Carvalheira JBC; Etchebehere ECSC; Santos AO; Miranda ECM; Lima MCL; Amorim BJ; de Souza CA; Lorand-Metze I; Ramos CD
Nucl Med Commun; 2020 Oct; 41(10):1081-1088. PubMed ID: 32732603
[TBL] [Abstract][Full Text] [Related]
17. Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myeloma.
Li Y; Liu J; Huang B; Chen M; Diao X; Li J
Oncotarget; 2017 Apr; 8(15):25637-25649. PubMed ID: 27556189
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma-amyloidosis presenting as pseudomyopathy.
Santos MS; Soares B; Mendes O; Carvalho CM; Casimiro RF
Rev Bras Reumatol; 2011 Dec; 51(6):651-4. PubMed ID: 22124598
[TBL] [Abstract][Full Text] [Related]
19.
Hemrom A; Tupalli A; Alavi A; Kumar R
PET Clin; 2022 Jul; 17(3):415-430. PubMed ID: 35717100
[TBL] [Abstract][Full Text] [Related]
20. Multimodality Molecular Imaging in Arthropathy Associated with Multiple Myeloma.
Almeida LS; de Souza SPM; de Souza FVP; Reis F; Ramos CD
Indian J Nucl Med; 2022; 37(3):290-292. PubMed ID: 36686291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
